Robert Jones
4PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Aug 04, 2025
Capivasertib/Fulvestrant in patients with HR+, HER2-low or HER2-negative locally advanced or metastatic breast cancer.Karam Aboud, Magda Meissner, Rob Jones
|Nov 23, 2024
Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial.Heinz-Josef Lenz, Tianshu Liu, Emerson Y Chen
|Nov 15, 2022
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.Robert Jones, Ruth Plummer, Victor Moreno
|Aug 19, 2022
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang
Pageof 1
Frequent Collaborators
2 joint publications
Udai Banerji
1 joint publications
Karam Aboud
1 joint publications
Magda Meissner
1 joint publications
Susana Banerjee
1 joint publications
Vasiliki Michalarea
1 joint publications
Joo Ern Ang
1 joint publications
Alvaro Ingles Garces
1 joint publications
Andrea Biondo
1 joint publications
Ionut-Gabriel Funingana
1 joint publications
Martin Little
